Our results can be validated in another cohort research, which reported that DNMT3A‐CHIP is significantly linked to worse initial stroke severity as measured by the NIHSS score and a higher risk of hemorrhagic transformation and functional disability at 90 days poststroke.7 This evidence concerns the gene DNMT3A and stroke disorder.